Advertisement

International Urogynecology Journal

, Volume 21, Issue 11, pp 1359–1364 | Cite as

Long-term outcome of transurethral injection of hyaluronic acid/dextranomer (NASHA/Dx gel) for the treatment of stress urinary incontinence (SUI)

  • Farah Lone
  • Abdul H. SultanEmail author
  • Ranee Thakar
Original Article

Abstract

Introduction and hypothesis

To investigate the long-term safety and efficacy of transurethral injection of NASHA/Dx gel in women suffering from stress urinary incontinence (SUI).

Methods

Women with SUI treated with NASHA/Dx gel via the transurethral Implacer™ device at Mayday University Hospital between November 2002 and December 2003 had long-term outcomes of therapy evaluated.

Results

Eighteen of 21 were followed-up at mean 6.7 years (±SD 0.15). One year after the injection, 11/21 (52.3%) reported improvement. Of the women, 6/21 (28.5%) had a repeat injection and seven (33.3%) women experienced adverse events in the form of periurethral swellings. At 6.7 years, only one of seven women was continent of urine without requiring any further continence procedure, 44.4% were still experiencing SUI symptoms. Nine of 18 (42.8%) had undergone other continence procedures.

Conclusion

Transurethral injection of NASHA/Dx gel in women with SUI is associated with complications and not effective in the long term.

Keywords

NASHA/Dx gel Stress urinary incontinence Urgency Urethral diverticulum Urethral abscess Tension-free vaginal tape 

Notes

Conflicts of interest

None.

References

  1. 1.
    Sahai A, Thomas M, Nedas T, Larner T, Niekrash R, Mohamed YH (2009) Periurethral non-animal stabilized hyaluronic acid/dextranomer injections: efficacy and formation of granuloma/sterile abscess. Urology 74(3):486–488CrossRefPubMedGoogle Scholar
  2. 2.
    Chapple CR, Haab F, Cervigni M, Dannecker C, Fianu-Jonasson A, Sultan AH (2005) An open, multicentre study of NASHA/Dx gel NASHA/Dx gel™ for the treatment of stress urinary incontinence. Eur Urol 48:488–494PubMedGoogle Scholar
  3. 3.
    Kerrebroeck VP, Meulen FT, Larsson G, Farrelly E, Edwall L, Fianu-Jonasson A (2004) Treatment of stress urinary incontinence using a copolymer system: impact on quality of life. BJU Int 94:1040–1043CrossRefPubMedGoogle Scholar
  4. 4.
    Bano F, Barrington JW, Dyer R (2005) Comparison between bovine dermal implant (permacol) and silicone injection (macroplastique) for urodynamic stress incontinence. Int Urogynecol J 16:147–150CrossRefGoogle Scholar
  5. 5.
    Abrams P, Cardozo L, Fall M et al (2002) The standardization of terminology of lower urinary tract dysfunction: report from the standardisation committee of the ICS. Neurol Urodyn 21:167–178CrossRefGoogle Scholar
  6. 6.
    Lightner D, Rovner E, Corcos J, Payne C, Brubaker L, Drutz H et al (2009) Randomized controlled multisite trial of injected bulking agents for women with intrinsic sphincter deficiency: mid-urethral injection of NASHA/Dx gel via implacer versus proximal urethral injection of contigen cystoscopically. Urology 74(4):771–775CrossRefPubMedGoogle Scholar
  7. 7.
    Maye R, Lightfoot M, Jung I (2001) Preliminary evaluation of calcium hydroxylapatite as a transurethral bulking agent for stress urinary incontinence. Urology 57:434CrossRefGoogle Scholar
  8. 8.
    Stenberg AM, Larsson E, Lindholm A, Ronneus B, Lackgren G (1999) Injectable dextranomer-based implant: histopathology, volume changes and DNA-analysis. Scand J Urol Nephrol 33:355–361CrossRefPubMedGoogle Scholar
  9. 9.
    Chi A, Gupta A, Snodgrass W (2008) Urinary tract infection following successful dextranomer/hyaluronic acid injection for vesicoureteral reflux. J Urol 179:1966–1969CrossRefPubMedGoogle Scholar
  10. 10.
    Dehli T, Lindsetmo RO, Mevik K, Vonen B (2007) Anal incontinence assessment of a new treatment. Tidsskr Nor Laegeforen 127(22):2934–2936PubMedGoogle Scholar
  11. 11.
    Hilton P (2009). Urethrovaginal fistula associated with ‘sterile abscess’ formation following periurethral injection of dextranomer/hyaluronic acid co-polymer (NASHA/Dx gel™) for the treatment of stress urinary incontinence—a case report. BJOG 1527-1530Google Scholar
  12. 12.
    Price N, Jackson SR, Avery K, Brookes ST, Abrams P (2006) Development and psychometric evaluation of the ICIQ vaginal symptoms questionnaire: the ICIQ-VS. BJOG 113(6):700–712CrossRefPubMedGoogle Scholar
  13. 13.
    Avery K, Donovan J, Abrams P (2001) Validation of a new questionnaire for incontinence: the international consultation on incontinence questionnaire (ICI-Q). Neurourol Urodyn 20:86Google Scholar
  14. 14.
    Bourcier AP, Juras JC (1995) Non surgical therapy for stress incontinence. Urol Clin N Am 22:613–627Google Scholar
  15. 15.
    Eckford SD, Abrahams D (1991) Para-urethral collagen implantation for female stress incontinence. Br J Urol 68:586–589CrossRefPubMedGoogle Scholar
  16. 16.
    Monga AK, Robinson D, Stanton SL (1995) Periurethral collagen injections for genuine stress incontinence: a 2-year follow-up. Br J Urol 76:156–160CrossRefPubMedGoogle Scholar
  17. 17.
    Bent AE, Foote J, Siegel S (2001) Collagen implant for treating stress urinary incontinence in women with urethral hypermobility. J Urol 166:1354–1357CrossRefPubMedGoogle Scholar
  18. 18.
    Stenberg AM, Larsson G, Johnson P (2003) Urethral injection for stress urinary incontinence: long-term results with dextranomer/hyaluronic acid copolymer. Int Urogynecol J 14:335–338CrossRefGoogle Scholar
  19. 19.
    Hagemeier T, Blau U, Gauruder-Burmester A, Tunn R (2006) Paraurethral abscess developing after mid-urethral NASHA/Dx gel-injection in women with stress urinary incontinence—management of complications and retrospective comparison with bladder neck located injection technique. Zentralbl Gynäkol 128(2):68–70CrossRefPubMedGoogle Scholar
  20. 20.
    Herschorn S, Satel E (2008) Periurethral collections following hyaluronic acid/dextranomer (NASHA/Dx gel) injection for female stress urinary incontinence. Europ Urol Supplements 7(3):146–2934CrossRefGoogle Scholar
  21. 21.
    Collet J, Shapiro S, Schick E, Macramallah E, Tessier J, Beneditti A (2000) Surgery vs. collagen for the treatment of female stress urinary incontinence (SUI): results of a multi-centric randomized trial. J Urol 165:819Google Scholar
  22. 22.
    Dmochowski RR, Appell RA (2000) Injectable agents in the treatment of stress urinary incontinence in women: where are we now? Urology 56:32CrossRefPubMedGoogle Scholar
  23. 23.
    Anderson G, Johansson JE, Garpenholt O, Nilsson K (2004) Urinary incontinence-prevalence, impact on daily living and desire for treatment: a population-based study. Scand J Urol Nephrol 38:125–130CrossRefGoogle Scholar
  24. 24.
    Sweat SD, Lightner DJ (1999) Complications of sterile abscess formation and pulmonary embolism following periurethral bulking agents. J Urol 161:93–96CrossRefPubMedGoogle Scholar
  25. 25.
    Lightner D, Calvosa C, Anderson R (2001) A new injectable bulking agent for treatment of stress urinary incontinence: results of a multicentre, randomized, controlled double blind study of durasphere. Urology 58(1):12–15CrossRefPubMedGoogle Scholar
  26. 26.
    Hanke CW, Higley HR, Jolivette DM, Swanson NA, Stegman SJ (1991) Abscess formation and local necrosis after treatment with zyderm or zyplast collagen implant. J Amer Acad Derm 25:319CrossRefGoogle Scholar
  27. 27.
    Herschorn S (2001) Current status of injectable agents for female stress urinary incontinence. Can J Urol 8:1281PubMedGoogle Scholar
  28. 28.
    Harriss DR, Iacovou JW, Lemberger RJ (1996) Periurethral silicone microimplants (macroplastique) for the treatment of genuine stress incontinence. Br J Urol 78:722–725PubMedGoogle Scholar
  29. 29.
    Loisel C, Secco M, Rocher-Barrat A, Caremel R, Grise P (2008) Periurethral pseudocysts following urethral injections of NASHA/Dx gel: review of the literature. Prog Urol 18(13):1038–1043, Epub 2008 Jul 22CrossRefPubMedGoogle Scholar
  30. 30.
    Lightner DJ (2002) Review of the available urethral bulking agents. Curr Opin Urol 12(4):333–338CrossRefPubMedGoogle Scholar

Copyright information

© The International Urogynecological Association 2010

Authors and Affiliations

  1. 1.Department of Obstetrics and GynaecologyMayday University HospitalCroydonSurrey

Personalised recommendations